CRISPR Therapeutics AG ($CRSP)
Filing Information
| Accession Number | 0001193125-26-007875 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
89,100
Total Value
$3,122,266.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Shares | โ | Jan 6, 2026 | Exercise/Conversion | 23,361 | $45.15 | $1,054,749.15 | 30,128 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Jan 6, 2026 | Exercise/Conversion | 6,339 | $44.31 | $280,881.09 | 36,467 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Jan 6, 2026 | Sale | 18,933 | $60.18 | $1,139,386.05 | 17,534 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Jan 6, 2026 | Sale | 5,004 | $60.00 | $300,240.00 | 12,530 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Jan 6, 2026 | Sale | 5,763 | $60.21 | $347,009.82 | 6,767 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jan 6, 2026 | Exercise/Conversion | 23,361 | $0.00 | $0.00 | 76,639 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jan 6, 2026 | Exercise/Conversion | 6,339 | $0.00 | $0.00 | 7,493 | Direct | โ | View Details |